DE10304950A1 - Herstellung von Tetrahydrochinolinbenzofuranen - Google Patents

Herstellung von Tetrahydrochinolinbenzofuranen Download PDF

Info

Publication number
DE10304950A1
DE10304950A1 DE10304950A DE10304950A DE10304950A1 DE 10304950 A1 DE10304950 A1 DE 10304950A1 DE 10304950 A DE10304950 A DE 10304950A DE 10304950 A DE10304950 A DE 10304950A DE 10304950 A1 DE10304950 A1 DE 10304950A1
Authority
DE
Germany
Prior art keywords
unsubstituted
polysubstituted
monosubstituted
case
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10304950A
Other languages
German (de)
English (en)
Inventor
Michael Przewosny
Werner Englberger
Klaus Schiene
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Priority to DE10304950A priority Critical patent/DE10304950A1/de
Priority to PE2004000123A priority patent/PE20050067A1/es
Priority to PCT/EP2004/001009 priority patent/WO2004069840A2/de
Priority to ARP040100360A priority patent/AR043034A1/es
Publication of DE10304950A1 publication Critical patent/DE10304950A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
DE10304950A 2003-02-06 2003-02-06 Herstellung von Tetrahydrochinolinbenzofuranen Withdrawn DE10304950A1 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE10304950A DE10304950A1 (de) 2003-02-06 2003-02-06 Herstellung von Tetrahydrochinolinbenzofuranen
PE2004000123A PE20050067A1 (es) 2003-02-06 2004-02-03 Preparacion de los tetrahidroquinolinbenzofuranos
PCT/EP2004/001009 WO2004069840A2 (de) 2003-02-06 2004-02-04 Herstellung von tetrahydrochinolinbenzofuranen
ARP040100360A AR043034A1 (es) 2003-02-06 2004-02-05 Preparacion de los tetrahidroquinolinbenzofuranos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10304950A DE10304950A1 (de) 2003-02-06 2003-02-06 Herstellung von Tetrahydrochinolinbenzofuranen

Publications (1)

Publication Number Publication Date
DE10304950A1 true DE10304950A1 (de) 2004-08-19

Family

ID=32730834

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10304950A Withdrawn DE10304950A1 (de) 2003-02-06 2003-02-06 Herstellung von Tetrahydrochinolinbenzofuranen

Country Status (4)

Country Link
AR (1) AR043034A1 (es)
DE (1) DE10304950A1 (es)
PE (1) PE20050067A1 (es)
WO (1) WO2004069840A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012079121A1 (en) * 2010-12-16 2012-06-21 Tuffrock Technology Pty Limited Improved mineral based composition and methods of use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10137487A1 (de) * 2001-08-03 2003-03-27 Gruenenthal Gmbh Substituierte 5,6,6a,11b-Tetrahydro-7-oxa-6-aza- benzo[c]fluoren-6-carbonsäurederivate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10005302A1 (de) * 2000-02-07 2002-01-17 Gruenenthal Gmbh Substituierte 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10137487A1 (de) * 2001-08-03 2003-03-27 Gruenenthal Gmbh Substituierte 5,6,6a,11b-Tetrahydro-7-oxa-6-aza- benzo[c]fluoren-6-carbonsäurederivate

Also Published As

Publication number Publication date
WO2004069840A2 (de) 2004-08-19
WO2004069840A3 (de) 2004-12-02
PE20050067A1 (es) 2005-02-18
AR043034A1 (es) 2005-07-13

Similar Documents

Publication Publication Date Title
WO2002089783A1 (de) Substituierte cyclohexan-1,4-diaminderivate mit antidiarrhoeischer und peripher analgetischer wirksamkeit
DD237510A5 (de) Verfahren zur herstellung von substituierten imidazo-(1,5-a)pyridin-derivaten
DE2846945A1 (de) Pharmazeutische praeparate
DE10005302A1 (de) Substituierte 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate
EP1317426B1 (de) Beta-thio-aminosäuren
DE2838892A1 (de) 2-substituierte-5-hydroxy-1h-imidazol-4-carboxamid-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
EP1406858B1 (de) Substituierte 4-aminocyclohexanole
WO2004043902A1 (de) 4-hydroxymethyl-1-aryl-cyclohexylamin-derivative
DE10236910A1 (de) Substituierte 1,2,3,4-Tetrahydrochinolinderivate
DE10053813A1 (de) Neue Verwendung von Sulfonamiden
DE102005027169A1 (de) Tetrahydrochinolinderivate
EP1406859B1 (de) Substituierte 4-aminocyclohexanolderivate
DE1695604A1 (de) N'-Phenylindolinderivate und Verfahren zu deren Herstellung
DE10304950A1 (de) Herstellung von Tetrahydrochinolinbenzofuranen
DE10053799A1 (de) Verwendung von Tetrahydroisochinolinsulfonamiden
EP1412361A1 (de) Substituierte 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluoren-6-carbonsäurederivate als nmda-antagonisten
EP0068240B1 (de) 2-Acylaminomethyl-1,4-benzodiazepin-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP1411947A2 (de) Salze substituierter 1,2,3,4-tetrahydrochinolin-2-carbonsaurederivate als nmda-antagonisten
DE2736652C2 (es)
CH649548A5 (de) 4-phenyl-4,5,6,7-tetrahydro-pyrrolo(2,3-c)pyridine, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese verbindungen enthalten.
DE2354931A1 (de) 2-phenylbicyclooctan-verbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DE2209844C3 (de) 4-(Alkylamino-alkyl)- [4H] -thieno [3,2-b] [f] benzazepine, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen
DE10053794A1 (de) Neue Verwendung für Amino- und Amidosulfonamide
DE2212693A1 (de) Dihydro-2-aminoisochinoline und Verfahren zu deren Herstellung
DE102006047231B4 (de) Substituierte Indeno[1,2-b]indolderivate als neue Hemmstoffe der Protein Kinase CK2 und ihre Verwendung als Tumor Therapeutika, Cytostatika und Diagnostika

Legal Events

Date Code Title Description
OM8 Search report available as to paragraph 43 lit. 1 sentence 1 patent law
8139 Disposal/non-payment of the annual fee